› Home › About us › Investment philosophy › Our portfolio › News & events › Contact › Investor login
Meet us at:
BioSpain 2008 »
Granada: September, 17 - 18 2008
Bio-Europe 2008 »
Mannheim/Heidelberg, Germany: November, 17 - 19 2008
 
At Forbion Capital Partners we invest in Life Sciences and Biomedical Technology companies developing world-class drugs and technologies, with a clear focus on product development.

Learn more »

'For Biotech and Beyond'
06.25.2008 AMT Announces Positive Interim Clincal Data on its Lead Product AMT-011  » 06.25.2008 AMT prepares for submission of Marketing Authorization Dossier for AMT-011 (GlyberaŽ)  » 06.25.2008 Biovex reports positive phase II clinical trial results of Oncovex GM-CSF in metastatic melanoma at the 2008 American Society of Clinical Oncology Meeting  »
Pictures

© Forbion 2006 All rights reserved